Idiopathic Hypersomnia (IH) Treatment Market

Idiopathic Hypersomnia (IH) Treatment Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

212

Base Year:

2023

Dec - 2024

Format:

Report Code:

VMR-3863

Segments Covered

By Drug Class Stimulant Medications, Non-stimulant wake-promoting Medications, Sodium Oxybate
By Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4199 USD

Multi User License

$ 6499 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2023
Forecast Years:	2024 - 2032
Historical Years:	2018 - 2022
Revenue 2023:	USD 340.4 Million
Revenue 2032:	USD 835.2 Million
Revenue CAGR (2024 - 2032):	8.5%
Fastest Growing Region (2024 - 2032)	Asia Pacific
Largest Region (2023):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Idiopathic Hypersomnia (IH) Treatment Market - Segment Analysis
1. Overview
2. Global Idiopathic Hypersomnia (IH) Treatment Market, 2016 - 2028 (USD Million)
3. Global Idiopathic Hypersomnia (IH) Treatment Market - by Drug Class
  1. By Stimulant Medications
  2. By Non-stimulant wake-promoting Medications
  3. By Sodium Oxybate
4. Global Idiopathic Hypersomnia (IH) Treatment Market - by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Online Pharmacies
5. Global Idiopathic Hypersomnia (IH) Treatment Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
6. Market comparative analysis
North America Idiopathic Hypersomnia (IH) Treatment Market - Segment Analysis
1. Overview
2. North America Idiopathic Hypersomnia (IH) Treatment Market, 2016 - 2028 (USD Million)
3. North America Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
  1. By Stimulant Medications
  2. By Non-stimulant wake-promoting Medications
  3. By Sodium Oxybate
4. North America Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Online Pharmacies
5. North America Idiopathic Hypersomnia (IH) Treatment Market, by Country
  1. U.S.
    1. U.S. Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. U.S. Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  2. Canada
    1. Canada Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. Canada Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  3. Mexico
    1. Mexico Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. Mexico Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
Europe Idiopathic Hypersomnia (IH) Treatment Market - Segment Analysis
1. Overview
2. Europe Idiopathic Hypersomnia (IH) Treatment Market, 2016 - 2028 (USD Million)
3. Europe Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
  1. By Stimulant Medications
  2. By Non-stimulant wake-promoting Medications
  3. By Sodium Oxybate
4. Europe Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Online Pharmacies
5. Europe Idiopathic Hypersomnia (IH) Treatment Market, by Country
  1. Germany
    1. Germany Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. Germany Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  2. UK
    1. UK Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. UK Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  3. France
    1. France Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. France Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  4. Spain
    1. Spain Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. Spain Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  5. Italy
    1. Italy Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. Italy Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  6. BENELUX
    1. BENELUX Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. BENELUX Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  7. Rest of Europe
    1. Rest Of Europe Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. Rest Of Europe Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
Asia Pacific Idiopathic Hypersomnia (IH) Treatment Market - Segment Analysis
1. Overview
2. Asia Pacific Idiopathic Hypersomnia (IH) Treatment Market, 2016 - 2028 (USD Million)
3. Asia Pacific Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
  1. By Stimulant Medications
  2. By Non-stimulant wake-promoting Medications
  3. By Sodium Oxybate
4. Asia Pacific Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Online Pharmacies
5. Asia Pacific Idiopathic Hypersomnia (IH) Treatment Market, by Country
  1. China
    1. China Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. China Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  2. Japan
    1. Japan Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. Japan Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  3. India
    1. India Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. India Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  4. South Korea
    1. South Korea Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. South Korea Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  5. South East Asia
    1. South East Asia Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. South East Asia Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. Rest of Asia Pacific Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
Latin America Idiopathic Hypersomnia (IH) Treatment Market - Segment Analysis
1. Overview
2. Latin America Idiopathic Hypersomnia (IH) Treatment Market, 2016 - 2028 (USD Million)
3. Latin America Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
  1. By Stimulant Medications
  2. By Non-stimulant wake-promoting Medications
  3. By Sodium Oxybate
4. Latin America Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Online Pharmacies
5. Latin America Idiopathic Hypersomnia (IH) Treatment Market, by Country
  1. Brazil
    1. Brazil Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. Brazil Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  2. Argentina
    1. Argentina Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. Argentina Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  3. Rest of Latin America
    1. Rest of Latin America Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. Rest of Latin America Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
Middle East & Africa Idiopathic Hypersomnia (IH) Treatment Market - Segment Analysis
1. Overview
2. Middle East & Africa Idiopathic Hypersomnia (IH) Treatment Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Idiopathic Hypersomnia (IH) Treatment Market, by Drug Class
  1. By Stimulant Medications
  2. By Non-stimulant wake-promoting Medications
  3. By Sodium Oxybate
4. Middle East & Africa Idiopathic Hypersomnia (IH) Treatment Market, by Distribution Channel
  1. By Hospital Pharmacies
  2. By Retail Pharmacies
  3. By Online Pharmacies
5. Middle East & Africa Idiopathic Hypersomnia (IH) Treatment Market, by Country
  1. GCC Countries
    1. GCC Countries Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. GCC Countries Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  2. South Africa
    1. South Africa Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. South Africa Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Idiopathic Hypersomnia (IH) Treatment Market, By Drug Class
      1. By Stimulant Medications
      2. By Non-stimulant wake-promoting Medications
      3. By Sodium Oxybate
    2. Rest of Middle East & Africa Idiopathic Hypersomnia (IH) Treatment Market, By Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Merck & Co. Inc.
2. Jazz Pharmaceuticals Inc.
3. Takeda Pharmaceutical Company Limited
4. Teva Pharmaceutical Industries Ltd.
5. BIOPROJET
6. Avadel Pharmaceuticals
7. PIc. GlaxoSmithKline plc
8. Pfizer Inc. Theranexus
9. Fisher & Paykel Healthcare Limited
10. Drive DeVilbiss Healthcare LLC
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 03-Jan-2025

Idiopathic Hypersomnia (IH) Treatment Market to Reach USD 835.2 Mn by 2035

FAQ

Frequently Asked Question

What is the global demand for Idiopathic Hypersomnia (IH) Treatment in terms of revenue?

The global Idiopathic Hypersomnia (IH) Treatment valued at USD 340.4 Million in 2023 and is expected to reach USD 835.2 Million in 2032 growing at a CAGR of 8.5%.

Which are the prominent players in the market?

The prominent players in the market are Merck & Co. Inc.,Jazz Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd.,BIOPROJET, Avadel Pharmaceuticals, PIc. GlaxoSmithKline plc, Pfizer Inc. Theranexus, Fisher & Paykel Healthcare Limited, Drive DeVilbiss Healthcare LLC.

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 8.5% between 2024 and 2032.

What are the driving factors fueling the growth of the market.

The driving factors of the Idiopathic Hypersomnia (IH) Treatment include

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Idiopathic Hypersomnia (IH) Treatment in 2023.

Idiopathic Hypersomnia (IH) Treatment Market

Idiopathic Hypersomnia (IH) Treatment Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Idiopathic Hypersomnia (IH) Treatment in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Idiopathic Hypersomnia (IH) Treatment Market

Idiopathic Hypersomnia (IH) Treatment Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Idiopathic Hypersomnia (IH) Treatment in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Idiopathic Hypersomnia (IH) Treatment Market

Vantage Point Interactive Dashboard